ImClone News
Most Popular ImClone Story
Alex Denner - The 25 most influential people in biopharma today
Good cop, bad cop Alex DennerHedge fund operator Carl Icahn may have received most of the credit, and certainly the lion's share of the cash, created by his high-profile biotech raiding parties. But Read more...
Latest Headlines
- February 7, 2012
- July 23, 2009
- January 14, 2009
- October 15, 2008
- October 6, 2008
- October 3, 2008
- October 2, 2008
- October 1, 2008
- September 29, 2008
- September 24, 2008
- September 23, 2008
- September 16, 2008
- September 12, 2008
- September 11, 2008
- September 10, 2008
- August 28, 2008
- August 21, 2008
- August 15, 2008
- August 11, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
